1 results match your criteria: "Department of Otolaryngology and Skull Base Surgery-Barrow Neurological Institute[Affiliation]"
A Systematic Review of Surgical Characteristics and Adverse Events of an Active, Transcutaneous Bone Conduction Device.
Ann Otol Rhinol Laryngol
November 2024
Department of Otolaryngology and Skull Base Surgery-Barrow Neurological Institute, Phoenix, AZ, USA.
Objective: A new, active transcutaneous bone conduction device (BCD) was FDA-approved in 2019 in the USA. This systematic review sought to evaluate early outcomes associated with Osia implantation.
Methods: A systematic review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines.